Literature DB >> 1731544

Clinical comparison of sevoflurane and isoflurane in healthy patients.

E J Frink1, T P Malan, M Atlas, L M Dominguez, J A DiNardo, B R Brown.   

Abstract

We compared blood pressure and heart rate changes in healthy patients during anesthesia with sevoflurane (n = 50) versus isoflurane (n = 25) and the rate of recovery after such anesthesia. After premedication with intravenous administration of midazolam, induction of anesthesia with thiopental, and intubation of the trachea facilitated with succinylcholine or vecuronium, anesthesia was maintained with approximately 1 MAC (sevoflurane, 2.05%; isoflurane, 1.15%) of the volatile anesthetic in oxygen for the duration of the operation. Anesthetic concentration was varied as indicated to maintain arterial blood pressure at +/- 20% of baseline values. Sevoflurane and isoflurane produced similar systolic and diastolic arterial blood pressures, but heart rate after incision was faster in patients given isoflurane. Recovery of response to command was shorter in patients given sevoflurane than that in patients given isoflurane (7.5 +/- 0.5 min versus 18.6 +/- 2.0 min). Consistent with this finding, venous blood drawn after anesthesia showed a more rapid initial decay with sevoflurane. Nausea and vomiting were comparable in both groups. We conclude that sevoflurane anesthesia, as compared with isoflurane, is associated with possible advantageous effects on heart rate and recovery.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1731544     DOI: 10.1213/00000539-199202000-00012

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  28 in total

1.  Comparison of the effects of sevoflurane and isoflurane anesthesia on the maternal-fetal unit in sheep.

Authors:  Toshiyuki Okutomi; Robert A Whittington; Deborah J Stein; Hisayo O Morishima
Journal:  J Anesth       Date:  2009-08-14       Impact factor: 2.078

2.  New volatile anaesthetics in cardiovascular anaesthesia: one step forward, two steps back?

Authors:  I R Thomson
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

Review 3.  What is the main mechanism of tramadol?

Authors:  Kouichiro Minami; Junichi Ogata; Yasuhito Uezono
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-21       Impact factor: 3.000

4.  Potentiation by sevoflurane of the gamma-aminobutyric acid-induced chloride current in acutely dissociated CA1 pyramidal neurones from rat hippocampus.

Authors:  J Wu; N Harata; N Akaike
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

5.  Comparison of sevoflurane/fentanyl and isoflurane/fentanyl during elective coronary artery bypass surgery. Sevoflurane Venture Group.

Authors:  N R Searle; R J Martineau; P Conzen; A al-Hasani; L Mark; T Ebert; M Muzi; L R Hodgins
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

Review 6.  New inhalational agents--desflurane and sevoflurane.

Authors:  E I Eger
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

7.  Effects of sevoflurane on voltage-gated sodium channel Na(v)1.8, Na(v)1.7, and Na(v)1.4 expressed in Xenopus oocytes.

Authors:  Toru Yokoyama; Kouichiro Minami; Yuka Sudo; Takafumi Horishita; Junichi Ogata; Toshihiko Yanagita; Yasuhito Uezono
Journal:  J Anesth       Date:  2011-06-08       Impact factor: 2.078

8.  Neuromuscular effects of sevoflurane in patients with myasthenia gravis.

Authors:  T Morita; H Tsukagoshi; D Kurosaki; T Sugaya; D Yoshikawa; H Shimada
Journal:  J Anesth       Date:  1996-09       Impact factor: 2.078

9.  Effects of preoperative oral melatonin medication on postoperative analgesia, sleep quality, and sedation in patients undergoing elective prostatectomy: a randomized clinical trial.

Authors:  Hale Borazan; Sema Tuncer; Naime Yalcin; Atilla Erol; Seref Otelcioglu
Journal:  J Anesth       Date:  2010-02-26       Impact factor: 2.078

Review 10.  Clinical pharmacokinetics of sevoflurane.

Authors:  M Behne; H J Wilke; S Harder
Journal:  Clin Pharmacokinet       Date:  1999-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.